Pacific Center for Financial Services’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $119K | Hold |
623
| – | – | 0.03% | 137 |
|
|
2026
Q1 | $105K | Buy |
623
+1
| +0.2% | +$171 | 0.03% | 136 |
|
|
2025
Q4 | $89.8K | Hold |
622
| – | – | 0.02% | 150 |
|
|
2025
Q3 | $89.8K | Hold |
622
| – | – | 0.02% | 150 |
|
|
2025
Q2 | $78.7K | Hold |
622
| – | – | 0.02% | 157 |
|
|
2025
Q1 | $79.5K | Buy |
622
+1
| +0.2% | +$136 | 0.02% | 154 |
|
|
2024
Q4 | $82.1K | Hold |
621
| – | – | 0.02% | 154 |
|
|
2024
Q3 | $90.4K | Buy |
621
+1
| +0.2% | +$145 | 0.02% | 140 |
|
|
2024
Q2 | $85.1K | Hold |
620
| – | – | 0.02% | 142 |
|
|
2024
Q1 | $85.1K | Buy |
620
+108
| +21% | +$14.7K | 0.02% | 145 |
|
|
2023
Q4 | $69.5K | Buy |
512
+1
| +0.2% | +$122 | 0.02% | 150 |
|
|
2023
Q3 | $62.4K | Sell |
511
-677
| -57% | -$86.1K | 0.02% | 157 |
|
|
2023
Q2 | $151K | Hold |
1,188
| – | – | 0.05% | 99 |
|
|
2023
Q1 | $153K | Buy |
+1,188
| New | +$156K | 0.05% | 94 |
|
|
2022
Q3 | $139K | Hold |
1,185
| – | – | 0.05% | 91 |
|
|
2022
Q2 | $139K | Buy |
1,185
+1
| +0.1% | +$119 | 0.06% | 94 |
|
|
2022
Q1 | $154K | Buy |
1,184
+1
| +0.1% | +$130 | 0.06% | 87 |
|
|
2021
Q4 | $181K | Buy |
1,183
+1
| +0.1% | +$155 | 0.07% | 77 |
|
|
2021
Q3 | $191K | Buy |
1,182
+108
| +10% | +$18.2K | 0.08% | 72 |
|
|
2021
Q2 | $176K | Buy |
1,074
+77
| +8% | +$11.9K | 0.08% | 74 |
|
|
2021
Q1 | $150K | Buy |
997
+48
| +5% | +$7.62K | 0.07% | 79 |
|
|
2020
Q4 | $144K | Buy |
949
+67
| +8% | +$9.57K | 0.05% | 76 |
|
|
2020
Q3 | $119K | Buy |
882
+1
| +0.1% | +$136 | 0.05% | 71 |
|
|
2020
Q2 | $120K | Buy |
881
+54
| +7% | +$6.88K | 0.06% | 71 |
|
|
2020
Q1 | $89K | Buy |
827
+50
| +6% | +$5.76K | 0.06% | 84 |
|
|
2019
Q4 | $94K | Buy |
777
+109
| +16% | +$12.2K | 0.04% | 90 |
|
|
2019
Q3 | $66K | Buy |
668
+63
| +10% | +$6.59K | 0.03% | 103 |
|
|
2019
Q2 | $66K | Buy |
605
+397
| +191% | +$42.2K | 0.03% | 103 |
|
|
2019
Q1 | $23K | Hold |
208
| – | – | 0.01% | 154 |
|
|
2018
Q4 | $20K | Hold |
208
| – | – | 0.01% | 161 |
|
|
2018
Q3 | $25K | Buy |
208
+1
| +0.5% | +$118 | 0.01% | 155 |
|
|
2018
Q2 | $23K | Hold |
207
| – | – | 0.01% | 147 |
|
|
2018
Q1 | $22K | Hold |
207
| – | – | 0.01% | 148 |
|
|
2017
Q4 | $22K | Hold |
207
| – | – | 0.01% | 145 |
|
|
2017
Q3 | $23K | Hold |
207
| – | – | 0.01% | 139 |
|
|
2017
Q2 | $21K | Hold |
207
| – | – | 0.01% | 142 |
|
|
2017
Q1 | $20K | Sell |
207
-813
| -80% | -$77.8K | 0.01% | 138 |
|
|
2016
Q4 | $90K | Buy |
+1,020
| New | +$92.8K | 0.07% | 74 |
|
Other funds holding IBB
CB
Pacific Center for Financial Services's IBB Position: Q2 2026 in Review
Pacific Center for Financial Services held its iShares Biotechnology ETF (IBB) position steady in Q2 2026 at 623 shares worth $119K. The position accounts for 0.03% of the portfolio, ranked #137.
Pacific Center for Financial Services first reported a position in IBB in Q4 2016 and has held it in 38 quarters since. The position peaked at $191K in Q3 2021. 954 funds tracked by Wall St. Rank hold IBB as of Q2 2026.
- Pacific Center for Financial Services held 623 shares of iShares Biotechnology ETF worth $119K as of Q2 2026.
- Pacific Center for Financial Services left its iShares Biotechnology ETF share count unchanged in Q2 2026.
- iShares Biotechnology ETF made up 0.03% of Pacific Center for Financial Services's portfolio in Q2 2026, its #137 holding.
- Pacific Center for Financial Services first reported a position in iShares Biotechnology ETF in Q4 2016 and has held it in 38 quarters since.
- Pacific Center for Financial Services's iShares Biotechnology ETF position peaked at $191K in Q3 2021.
- 954 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.
Based on Pacific Center for Financial Services's 13F filing for Q2 2026, filed 5 Aug 2026.